Febuxostat
Febuxostat
8 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Febuxostat
Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Ascend Laboratories, LLC | generic | 8 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | generic | 7 | SUPPLYING |
| SUN PHARMACEUTICAL INDUSTRIES, INC. | generic | 6 | SUPPLYING |
| Major Pharmaceuticals | relabeler | 4 | SUPPLYING |
| NuCare Pharmaceuticals,Inc. | repackager | 2 | SUPPLYING |
| NorthStar RxLLC | relabeler | 2 | SUPPLYING |
| Aphena Pharma Solutions - Tennessee, LLC | repackager | 1 | SUPPLYING |
| American Health Packaging | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide
CGMP Deviations — Recalling firm: Amerisource Health Services LLC — USA Nationwide
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA